ATA80390A - PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES - Google Patents

PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES

Info

Publication number
ATA80390A
ATA80390A AT0080390A AT80390A ATA80390A AT A80390 A ATA80390 A AT A80390A AT 0080390 A AT0080390 A AT 0080390A AT 80390 A AT80390 A AT 80390A AT A80390 A ATA80390 A AT A80390A
Authority
AT
Austria
Prior art keywords
hemicelluloses
active substance
pharmaceutical preparation
substance release
release based
Prior art date
Application number
AT0080390A
Other languages
German (de)
Other versions
AT397345B (en
Original Assignee
Chemiefaser Lenzing Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemiefaser Lenzing Ag filed Critical Chemiefaser Lenzing Ag
Priority to AT0080390A priority Critical patent/AT397345B/en
Priority to EP90890337A priority patent/EP0450262A1/en
Priority to US07/676,977 priority patent/US5151273A/en
Priority to JP3069674A priority patent/JPH06206833A/en
Publication of ATA80390A publication Critical patent/ATA80390A/en
Application granted granted Critical
Publication of AT397345B publication Critical patent/AT397345B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AT0080390A 1990-04-04 1990-04-04 PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES AT397345B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT0080390A AT397345B (en) 1990-04-04 1990-04-04 PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES
EP90890337A EP0450262A1 (en) 1990-04-04 1990-12-18 Pharmaceutical preparation with delayed drug release
US07/676,977 US5151273A (en) 1990-04-04 1991-03-29 Delayed-release pharmaceutical preparation
JP3069674A JPH06206833A (en) 1990-04-04 1991-04-02 Pharmaceutical drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0080390A AT397345B (en) 1990-04-04 1990-04-04 PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES

Publications (2)

Publication Number Publication Date
ATA80390A true ATA80390A (en) 1993-08-15
AT397345B AT397345B (en) 1994-03-25

Family

ID=3500064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0080390A AT397345B (en) 1990-04-04 1990-04-04 PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES

Country Status (4)

Country Link
US (1) US5151273A (en)
EP (1) EP0450262A1 (en)
JP (1) JPH06206833A (en)
AT (1) AT397345B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100187343B1 (en) * 1992-08-07 1999-03-20 히사모또 고이찌로 Binder and product made by using the same
WO1994007469A1 (en) * 1992-09-25 1994-04-14 Dynagen, Inc. An immunobooster for delayed release of immunogen
EP1039881A1 (en) * 1997-12-18 2000-10-04 Ato B.V. Composition for the controlled release of active compounds
JP5558648B2 (en) * 1998-11-23 2014-07-23 デイビス、ボニー Administration formulation for acetylcholinesterase inhibitors
US7160559B1 (en) 1998-12-24 2007-01-09 Janssen Pharmaceutica N.V. Controlled release galantamine composition
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
ATE340563T1 (en) * 2000-02-04 2006-10-15 Depomed Inc SHELL AND CORE TYPE DOSAGE FORM WITH A RELEASE OF ACTIVE INGREDIENTS APPROACHING TO THE ZERO ORDER
FR2811227A1 (en) * 2000-07-07 2002-01-11 Philippe Maincent PARTICULATE VECTORS FOR IMPROVING ORAL ABSORPTION OF ACTIVE PRINCIPLES
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
KR100628263B1 (en) * 2002-08-21 2006-09-27 엘지.필립스 엘시디 주식회사 Liquid crystal display device
CA2575739A1 (en) * 2004-08-06 2006-02-16 Grain Processing Corporation Tablet coating composition
US20090028941A1 (en) * 2007-07-27 2009-01-29 Depomed, Inc. Pulsatile gastric retentive dosage forms
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
JP5250285B2 (en) * 2008-03-26 2013-07-31 富士フイルム株式会社 Oral dressing, edible container and oral product using them
EP2970839B1 (en) * 2013-03-15 2017-02-22 Monosol, LLC Water-soluble film for delayed release
US10808210B2 (en) 2013-03-15 2020-10-20 Monosol, Llc Water-soluble film for delayed release

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130545A1 (en) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmaceutical molded body
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
JPS6042766B2 (en) * 1978-12-09 1985-09-25 日本化薬株式会社 Base
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
DE3000979A1 (en) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach NEW DIPYRIDAMOL RETARD FORMS AND METHOD FOR THEIR PRODUCTION
US4456628A (en) * 1981-01-07 1984-06-26 Bauer Kurt H Process for film-coating a particulate solid, and emulsions for conducting the process
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4581359A (en) * 1984-04-23 1986-04-08 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Pharmacological treatments with N-7-substituted derivatives of theophylline
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
SE8601563D0 (en) * 1986-04-08 1986-04-08 Carbomatrix Ab MATERIAL MATERIAL, PROCEDURES FOR PREPARING IT AND USING IT
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
DE3630603A1 (en) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh PHARMACEUTICAL AND DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES, REAGENTS OR THE LIKE, AND METHOD FOR THE PRODUCTION THEREOF
JPH0725689B2 (en) * 1986-10-07 1995-03-22 中外製薬株式会社 Sustained-release preparation containing granulocyte colony-stimulating factor
DE3784875T2 (en) * 1986-12-18 1993-08-19 Syntex Inc STABLE, ESTER-ANTIBIOTIC CONTAINING ANIMAL FEED.
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
JP2683391B2 (en) * 1988-11-30 1997-11-26 日清製粉株式会社 Sustained release composition based on hemicellulose from wheat bran

Also Published As

Publication number Publication date
AT397345B (en) 1994-03-25
EP0450262A1 (en) 1991-10-09
JPH06206833A (en) 1994-07-26
US5151273A (en) 1992-09-29

Similar Documents

Publication Publication Date Title
DE3880593D1 (en) MEDICINAL PREPARATIONS WITH RETARDED ACTIVE SUBSTANCE RELEASE.
DE3868037D1 (en) PHARMACEUTICAL COMPOSITION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE.
DE69000881D1 (en) MEDICINE PREPARATION CONTAINING 2-PROPYLVALERIC ACID WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE.
ATA80390A (en) PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES
DE3688532D1 (en) PHARMACEUTICAL PHARMACEUTICAL FORM WITH DELAYED DELIVERY.
DE3778723D1 (en) EASILY ABSORBABLE PHARMACEUTICAL PREPARATION.
DE59003337D1 (en) Pressling with delayed release of active ingredient.
DE3782840D1 (en) MEDICINAL PRODUCTS WITH DELAYED RELEASE.
DE68901417D1 (en) PHARMACEUTICAL COMPOSITION.
DK137488D0 (en) PREPARATIONS WITH CONTROLLED ACTIVE SUBSTANCES
DE3676235D1 (en) DRUG PREPARATION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE.
DE69101931D1 (en) Pharmaceutical composition.
DE69117793D1 (en) Medication infusion system
NO912732D0 (en) PHARMACEUTICAL AGENTS WITH PLATINA.
DE69014498D1 (en) Hyposensitizing active substance.
DE68909772T2 (en) Diclofenac sodium pharmaceutical preparation with extended release of active ingredient.
DE3781034T2 (en) TOPICAL PHARMACEUTICAL PREPARATION WITH BETTER PENETRAPHABILITY.
FI925778A (en) PHARMACEUTICAL ACTIVE benzoquinazoline active ingredient
DE3771611D1 (en) BUTENIC ACID-N-PHENYLAMIDES WITH PHARMACEUTICAL PROPERTIES.
DE68905573T2 (en) EASILY ABSORBENT MEDICAL PREPARATION.
DE3881208D1 (en) PEST REPELLENT MICROCAPSULES WITH DELAYED DELIVERY.
FR2641190B3 (en) NEEDLELESS INJECTOR
NO910022D0 (en) FUNGISIDE ACTIVE SUBSTANCE COMBINATIONS.
FI923371A0 (en) EN PHARMACEUTICAL FORMULATION.
DK137591D0 (en) FIXED PHARMACEUTICAL PREPARATION

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee